18.6 C
New York
Monday, September 26, 2022

Compass explores psychedelic meds with UK institutions | 2021-07-06


Compass Pathways Ltd. has joined with a U.K. hospital and an academic establishment to research the role of psychedelic medicine in new models of mental health care. The London-based company signed a memorandum of understanding with South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology and Neuroscience at King’s College London to launch the project.

BioWorld Drugs Research Neurology/Psychiatric Europe



Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

five × three =

Stay Connected

0FansLike
3,498FollowersFollow
0SubscribersSubscribe

Latest Articles